Carratu, Pierluigi, Massroor Pourcyrous, Alex Fedinec, Charles W. Leffler, and Helena Parfenova. Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. Am J Physiol Heart Circ Physiol 285: H1148-H1157, 2003; 10.1152/ajpheart.00091. 2003.-In newborn pigs, the mechanism of seizure-induced cerebral hyperemia involves carbon monoxide (CO), the vasodilator product of heme catabolism by heme oxygenase (HO). We hypothesized that seizures cause cerebral vascular dysfunction when HO activity is inhibited. With the use of cranial window techniques, we examined cerebral vascular responses to endothelium-dependent (hypercapnia and bradykinin) and endothelium-independent (isoproterenol and sodium nitroprusside) dilators during the recovery from bicuculline-induced seizures in saline controls and in animals pretreated with a HO inhibitor, tin protoporphyrin (SnPP). SnPP (3 mg/kg iv) blocked dilation to heme and reduced the CO level in cortical periarachnoid cerebrospinal fluid, indicating HO inhibition in the cerebral microcirculation. In saline control piglets, seizures increased the CO level, which correlated with the time-dependent cerebral vasodilation; during the recovery (2 h after seizure induction), responses to all vasodilators were preserved. In SnPP-treated animals, cerebral vasodilation and the CO responses to seizures were greatly reduced, and cerebral vascular reactivity was severely impaired during the recovery. These findings suggest that HO in the cerebral microcirculation is rapidly activated during seizures and provides endogenous protection against seizure-induced vascular injury.
SEIZURES ARE THE MANIFESTATION of abnormal synchronous neuronal discharges in the cerebral cortex. Seizure results when a sudden imbalance occurs between the excitatory and inhibitory forces in favor of net excitation of cortical neurons. In neonates, recurrent seizures may result from meningitis, intracranial injuries and hemorrhage, asphyxia and hypoxia, and metabolic disorders such as hypoglycemia, hypocalcemia, and hyponatremia (2, 38) . Seizures in the neonatal period may result in neuronal damage and susceptibility to epilepsy in survivors. Seizures induce a dramatic increase in blood flow to the brain in different animal models and in humans (2, 4, 6, 13, 23, 24, 30, 31) . Increased blood flow to the brain cortex is necessary to match metabolic demands of hyperactive neurons and to ameliorate excitotoxic brain damage.
Mechanisms by which seizures increase blood flow to the brain may involve heme oxygenase (HO). HO inhibitors greatly reduced cerebral hyperemia caused by seizures in rats and newborn pigs (24, 30) . HO, a rate-limiting enzyme in heme degradation to biliverdin and carbon monoxide (CO), is highly expressed in the brain and in cortical microvessels (18, 20) . CO is a potent vasodilator in the cerebral microcirculation of newborn pigs (15, 18) . HO isoforms include inducible HO-1 (heat shock protein 32) and constitutive HO-2 (20) . HO-1 is rapidly upregulated in response to stress and growth factors (20) . Under basal conditions, high expression and activity of constitutive HO-2 is found in the brain tissue and in cortical microvessels (18, 20, 27) .
Glutamate is a major excitatory neurotransmitter in the brain. Excessive neuronal release of glutamate, imbalance between inhibitory and excitatory neurotransmitters, and decreased reuptake result in the accumulation of extracellular glutamate in the brain during seizures (22) . Glutamate is a vasodilator in the cerebral circulation (5, 32) . Dilator effects of glutamate may involve a CO-mediated mechanism. In the cerebral microcirculation of newborn pigs, glutamate stimulates CO production and causes CO-dependent vasodilation. CO production by cerebral microvessels and cerebral microvascular endothelial cells from newborn pigs is stimulated by glutamate via an ionotropic glutamate receptor-mediated mechanism (26, 32) . Isolated cerebral arterioles respond to glutamate by endothelium-dependent vasodilation, which can be blocked by HO inhibitors (15) . In vivo, activation of N-methyl-D-aspartate (NMDA) and ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors results in CO-dependent dilation of pial arterioles (32) . These data indicate that activation of HO in the cerebral microcirculation via a glutamate receptor-mediated mechanism may contribute to the increased cerebral blood flow response to seizures. HO activation during seizures may protect against excitotoxic injury in the cerebral microcirculation. The products of the HO pathway, CO biliverdin, and its end metabolite, bilirubin, have protective effects against cell injury and oxidative stress (9, 10, 20, 35) .
We hypothesized that seizures cause severe impairment of cerebral vascular functions when HO enzymatic activity is inhibited. In a newborn pig model of bicuculline-induced seizures in vivo, we addressed the following questions: 1) do seizures cause HO activation in the brain? 2) do seizures cause cerebral vascular dysfunction during the recovery period? and 3) is HO activation important in preventing cerebral vascular dysfunction? To assess HO activity/expression in the brain before and during seizures, we measured the CO concentration in cortical periarachnoid cerebrospinal fluid (CSF) and expression of the HO-1 and HO-2 isoforms in cerebral microvessels. With the use of cranial window techniques, we examined cerebral vascular reactivity to endothelium-dependent (hypercapnia and bradykinin) and endothelium-independent (isoproterenol and sodium nitroprusside) stimuli during the recovery from seizures in control animals and in animals with inhibited HO activity. To inhibit HO activity in the brain, we used a synthetic nonmetabolized heme analog, tin protoporphyrin (SnPP), a potent competitive inhibitor of HO, which binds to the active site of the enzyme (1). In newborn animals, systemically administered SnPP (7-30 mg/kg iv) effectively inhibits HO activity in all organs, including the brain (11, 21) .
METHODS
Protocols using animals were approved by the Animal Care and Use Committee of the University of Tennessee Health Science Center.
Catheter and cranial window placement. Newborn pigs (1-5 days old, 1.5-2.5 kg) were initially anesthetized with ketamine hydrochloride (33 mg/kg im) and acepromazine (3.3 mg/kg im) and maintained on ␣-chloralose (30) . Although ketamine is a NMDA antagonist, it was used only for initial anesthesia. Because the effects of ketamine-acepromazine anesthesia are transient (piglets regain consciousness in 15-20 min), the residual effects of ketamine on cerebral vascular responses to glutamate receptor agonists are negligent in our experimental model (5, 32) . The catheters were placed into a femoral vein for infusion of 5% dextrose saline (4 ml ⅐ kg Ϫ1 ⅐ h Ϫ1 ) and SnPP (3 mg/kg when indicated). Another catheter was inserted into the abdominal aorta via a femoral artery for recording blood pressure and for sampling of blood for pH and gases. The animals were ventilated with room air. Before seizure induction, arterial blood gases and pH were maintained as follows: arterial PO 2 (PaO 2 ) ϳ90 mmHg, arterial PCO2 (PaCO 2 ) ϳ40 mmHg, and pH ϳ7.45. Mean arterial blood pressure (MABP) was within a range of 60-80 mmHg. Body temperature was maintained at 37-38°C with a servo-controlled heating pad. The animals were equipped with a stainless steel cranial window that allowed 1) measurement of pial arteriolar diameter with a videomicrometer coupled to a television camera, 2) delivery of drugs directly to the brain surface through the ports of the window, and 3) cortical periarachnoid CSF collection. The space under the window was filled with artificial CSF (aCSF), which contained (in mM) 3.0 KCl, 1.5 MgC 2, 1.5 CaCl2, 132 NaCl, 6.6 urea, 3.7 dextrose, and 24.6 NaHCO 3, equilibrated with 6% CO 2-6% O2-88% N2 to pH 7.3-7.35 at 37°C. To detect cerebral production of CO, cortical periarachnoid CSF (500 l) was sampled from under the window.
Seizure induction. Seizures were induced by administration of bicuculline (3 mg/kg iv) (6, 30, 31) . Bicuculline, a GABA receptor blocker, induces spontaneous seizures by disruption of the normal balance between excitatory and inhibitory neurotransmitters. Shortly before the experiment, bicuculline was dissolved in 0.1 N HCl (3 mg/ml), neutralized with 1 N NaOH to pH 4-5, and diluted with 5 ml saline. Bicuculline-induced seizures are characterized by abnormal electrocortical activity, increased intracranial pressure, and increased heart rate (HR) sustained for over a 1-h period (6, 31) . Animals were paralyzed with pancuronium bromide (0.2 mg/kg iv). Pancuromium attenuates the increase in MABP and stabilizes arterial blood gases and pH without affecting the cerebral blood flow response to seizures (31) . Additional injections of pancuronium (0.1 ml/kg) were given if visible evidences of seizures were seen. To inhibit HO activity, SnPP (3 mg/kg) was administered 30 min before seizure induction. Although different metalloporphyrins (ZnPP, CrMP, and SnPP) effectively inhibit HO activity and HO-mediated cerebral vascular responses in vivo and in vitro (17, 18, 26, 27, 32) , we selected SnPP because it was more effective in inhibiting cerebral dilation to seizures and was better tolerated by animals upon systemic administration (30) . SnPP was dissolved in 10% ethanolamine (stock solution, 15 mg/ml) and kept protected from light. Before use, SnPP was diluted with saline (1:30) and administered intravenously by a 0.45-m Millipore filter-equipped syringe. Pial arteriolar diameter, HR, and MABP were constantly monitored for 2 h after seizure induction. Blood gases were measured every 20 min, and adjustments in ventilation were made to assure that blood gases remained within physiological ranges. Cortical periarachnoid CSF (500 l) was sampled from under the window every 10 min for detection of cerebral production of CO. Two hours after the bicuculline injection, cerebral vascular reactivity to endothelium-dependent and -independent stimuli was tested.
Vascular reactivity. To test vascular reactivity, we used endothelium-dependent dilator stimuli, hypercapnia and bradykinin, and endothelium-independent vasodilators, isoproterenol and sodium nitroprusside. In addition, the responses of pial arterioles to the topical HO substrate, heme [as heme-L-lysinate (HLL)], were tested to probe for functional activity of HO in the cerebral microcirculation. Three pial arterioles (60-80 m) in each animal were selected for observation. To determine the control diameter values, arterioles were measured over a 10-min period during basal conditions. Hypercapnia (PaCO 2 , 84 Ϯ 5 mmHg, PaO 2 , 100 Ϯ 8 mmHg, pH 7.00 Ϯ 0.05) was induced for 10 min by ventilating piglets with a mixture of 10% CO2 and 21% O2 in 69% N2. At the end of the hypercapnia period, the ventilation gas was returned to air, and the cerebral surface was flushed with aCSF for 20 min to allow arterial blood gases, pH, and pial arteriolar diameter to return to basal values. Bradykinin at progressively increasing concentrations (10 Ϫ6 and 10 Ϫ5 M) was applied to the cerebral surface, and changes in pial arteriolar diameter were recorded. After the cerebral surface was flushed with aCSF for 20 min, pial arteriolar diameter returned to the basal level, and isoproterenol (10 Ϫ6 and 10
Ϫ5
M) was applied. The brain surface was flushed with aCSF, and HLL at increasing concentrations (10 Ϫ8 , 10 Ϫ7 , and 10
Ϫ6
M) was applied. HLL solution in aCSF was protected from light at all times, and the cranial window was illuminated only shortly for the pial arteriolar diameter measurements.
Pial arteriolar diameter measurements in response to topical compounds were taken three times over a 10-min period after the application of each concentration. The stable diameter achieved between 5 and 10 min was taken as the response. At the end of the experiment, the brain was rapidly removed, and cerebral microvessels were isolated to detect HO protein expression. Experimental groups. To investigate the effects of seizures on cerebral vascular reactivity, vascular responses to hypercapnia, bradykinin, isoproterenol, sodium nitroprusside, and HLL were tested in 1) intact animals (group I, n ϭ 12); 2) animals during the seizure recovery period (2 h after bicuculline injection, saline control-seizure, group II, n ϭ 7); and 3) SnPP-pretreated animals during the seizure recovery period (2 h after bicuculline injection, SnPP-seizure, group III, n ϭ 7). To evaluate SnPP selectivity, we investigated the acute (30 min) and prolonged (2 h) effects of SnPP (3 mg/kg iv by single injection) on cerebral vascular reactivity to the above stimuli (SnPP control, group IV, n ϭ 9; and SnPP control, group V, n ϭ 9, respectively).
Detection of CO in cortical periarachnoid CSF by gas chromatography/mass spectrometry. To collect CSF, 1 ml of aCSF was slowly infused through the port of the cranial window onto the brain surface, and drops of CSF from the opposite port were collected. The CSF samples were transferred to amber vials (2 ml), and the total volume was adjusted to 1.7 ml with aCSF. The internal standard (5 l) of a saturated solution of heavy 13 C 16 O (isotopic purity Ͼ99%, 1 mM, Isotech; Miamisburg, OH) was injected into the bottom of the vial (26) . The vials were sealed with Teflon-lined caps, and the samples were left overnight at room temperature. The samples were placed in hot water (75°C) for 30 min. The headspace gas mixture was analyzed by a Hewlett-Packard 5970 ion detector interfaced to a Hewlett-Packard 5890A gas chromatograph. The separation of CO was carried out on a Varian-5A Molesieve capillary column (30 m, 0.32 mm internal diameter, Varian) with a linear temperature gradient from 35 to 65°C. Helium was the carrier gas at a column head pressure of 4.0 psi. Aliquots (100 l) of the headspace gas were injected with a gas-tight syringe into the injector (120°C). Ions at a mass-to-charge ratio (m/z) of 28 and 29, corresponding to 12 C 16 O and 13 C 16 O, respectively, were recorded via selective ion monitoring. The amount of CO was calculated from the ratio of the peak areas of m/z 28 and m/z 29.
Isolation of cerebral microvessels and Western immunoblotting. Cerebral microvessels (60-300 m) were isolated from the brain cortex by differential filtration of the tissue homogenate through nylon 300-and 60-m mesh screens (27) . Microvessels were homogenized in 1 ml of 10 mM Tris-1% SDS, pH 7.4, containing 1 mM sodium orthovanadate, and heated at 100°C for 5 min. Proteins (50 g/lane) were separated by 9% SDS-PAGE, transferred to nitrocellulose membranes, and blocked with 5% BSA-0.1% Tween 20. The membranes were probed with polyclonal anti-human HO-2 (1:5,000 dilution, SPA 897 from StressGen; Victoria, Canada) or polyclonal anti-human HO-1 (1:5,000 dilution, SPA 895 from StressGen), followed by peroxidase-conjugated donkey anti-rabbit IgG (dilution 1:10,000, Jackson Immunoresearch; West Grove, PA). As positive controls, we used recombinant rat HO-1 and human HO-2 proteins (StressGen). For quantification purposes, the membranes were reprobed with monoclonal antibodies against actin (dilution 1:10,000, Chemicon International; Temecula, CA), followed by peroxidase-conjugated donkey anti-mouse IgG (Jackson Immunoresearch). Bands were visualized with the Renaissance chemiluminescence kit (NEN Life Science Products; Boston, MA) and quantified by digital densitometry using NIH Image 1.63.
Statistical analysis. Values are presented as means Ϯ SE of absolute values or as a percentage of control. ANOVA with repeated measures and Fisher's protected least-significantdifference test were used to confirm differences among and then between groups, respectively. A level of P Ͻ 0.05 was considered significant in all statistical tests.
Materials. HLL was prepared using methods described previously (17) . SnPP was purchased from Porphyrin Products (Logan, UT). Pancuronium bromide was from Astra Pharmaceutical Products (Westborough, MA). Bicuculline, bradykinin, isoproterenol, and sodium nitroprusside were from Sigma (St. Louis, MO).
RESULTS

Effects of SnPP in the cerebral and systemic circulation.
Systemic administration of SnPP (3 mg/kg iv) caused no changes in basal pial arteriolar diameter (diameter change, 5 Ϯ 2% of the control value 30 min after administration), MABP (64 Ϯ 4, 65 Ϯ 2, and 65 Ϯ 2 mmHg detected before and 15 and 30 min after the inhibitor administration, respectively), and HR (123 Ϯ 5, 123 Ϯ 5, and 122 Ϯ 5 beats/min before and 15 and 30 min after the inhibitor administration, respectively).
Time-dependent cerebral vascular effects of SnPP on HO-mediated responses.
To characterize the functional expression of HO in the cerebral microcirculation and to confirm that systemic SnPP does inhibit HO in the cerebral microcirculation, we studied the responses of pial arterioles to HLL, a HO substrate (Fig. 1) . In intact piglets, HLL (10 Ϫ8 -10 Ϫ6 M) caused dose-dependent vasodilation of pial arterioles (maximal dilation, 38 Ϯ 5%, was achieved at 10 Ϫ7 M). In animals pre- (Fig. 2) . SnPP did not inhibit cerebral vasodilation to sodium nitroprusside (10 Ϫ6 M), as evaluated 30 min or 2 h after the inhibitor administration (Fig. 2) . Low effectiveness or inability of SnPP to inhibit responses of pial arterioles to hypercapnia, isoproterenol, and sodium nitroprusside indicates that the HO inhibitor has very little nonspecific effect in the cerebral circulation.
In contrast to the results with hypercapnia, isoproterenol, and sodium nitroprusside, in piglets pretreated with SnPP for 30 min, dilation of pial arterioles to the endothelium-dependent dilator bradykinin (10 Ϫ6 -10 Ϫ5 M) was greatly inhibited (70-80% inhibition; Fig. 3 ). These results indicate that HO/CO may contribute to cerebral vasodilation in response to bradykinin. The inhibitory effect of SnPP on the dilator responses to bradykinin is reversible, as is the case with the heme substrate. By 2 h after SnPP administration, the vasodilation to bradykinin returned near to the control level (Fig. 3) .
Effects of seizures on the cerebral and systemic circulation. Bicuculline (3 mg/kg iv) caused immediate and sustained dilation of pial arterioles. Maximal vasodilation (Ͼ1.8-fold above the baseline) was observed during the first 2-5 min of seizures (Fig. 4) . In animals with intact HO activity, dilation of pial arterioles (1.4-to 1.6-fold above the basal diameter) was sustained for 2 h after seizure induction (Fig. 4) . However, when HO activity was inhibited at the seizure onset, time-dependent cerebral vasodilation to seizures was greatly reduced. In SnPP-treated animals, initial dilation (1.5-fold above the baseline in 2-10 min of seizure induction) was followed by a rapid return of pial arteriolar diameter to near the basal level in 1 h (Fig. 4) .
We investigated whether SnPP affects systemic cardiovascular effects of seizures. Seizures caused immediate and sustained increase in HR (from ϳ120 to ϳ200 beats/min; Fig. 5A ) and a transient moderate increase in MABP (from 60-70 to 75-80 mmHg in 2-10 min; Fig. 5B ) in both control and SnPP-treated groups of piglets. Arterial blood gases were constantly monitored and maintained at physiological levels for the duration of seizures in control and SnPP-treated piglets: Pa CO 2 , 30-40 mmHg (Fig. 5C) ; and Pa O 2 , 95 Ϯ 5 mmHg. Bicuculline administration resulted in an immediate drop in blood pH from 7.34 Ϯ 0.01 to 7.24 Ϯ 0.01, indicating a moderate shift toward metabolic acidosis during seizures that was slightly more accen- Responses of pial arterioles to bradykinin (10 Ϫ6 and 10 Ϫ5 M) were determined in intact piglets (intact control, group I, n ϭ 12) and in animals pretreated with SnPP (3 mg/kg iv) for 30 min (SnPP control, group IV, n ϭ 9) or for 2 h (SnPP control, group V, n ϭ 9) before the experimentation. Values are means Ϯ SE for each treatment group. *P Ͻ 0.05 compared with the intact control group. tuated in SnPP-treated group of piglets (Fig. 5D) . Overall, SnPP administration did not cause any major changes in systemic responses to seizures.
Effects of seizures on the CO level in cortical periarachnoid CSF. We detected CO in cortical periarachnoid CSF by gas chromatography/mass spectrography. In control animals during resting conditions, the CO level was 88 Ϯ 20 pmol/ml CSF (n ϭ 25); therefore, the CO concentration in cortical periarachnoid CSF corresponded to 9 Ϯ 2 ϫ 10 Ϫ8 M. Injection of pancuronium bromide (0.2 mg/kg) did not alter the CO level. Seizures caused an immediate and sustained increase of CO in cortical periarachnoid CSF. The maximal increase in CO concentration (20-to 30-fold over the baseline) was observed in the first 10 min after seizure induction (Fig. 6) . The CO production was maintained at the increased level (5-to 10-fold above the baseline) for the first 1 h of seizures. By 2 h after seizure induction, CO returned to the basal level (Fig. 6) . Overall, the timedependent dynamics of CO concentration in cortical periarachnoid CSF followed the changes in pial arteriolar diameter during seizures. We observed a good correlation between the increase in pial arteriolar diameter and the CO level in CSF (correlation coefficient ϭ 0.63, P Ͻ 0.05; Fig. 7 ). SnPP (3 mg/kg iv) in 30 min decreased the basal cortical CSF CO level by 30-50% (114 Ϯ 26 and 61 Ϯ 12 pmol/ml before and after SnPP injection, n ϭ 15), indicating inhibition of the HO enzymatic activity in the brain. In SnPPtreated piglets, a significant increase in CO (4-fold above the baseline) was observed only during first 10 min of seizures (Fig. 6) . At all time points during active seizures (1-h period), the CO level in CSF was significantly lower in SnPP-treated piglets than in the untreated animals (Fig. 6) .
HO-1 and HO-2 expression in cerebral microvessels.
We compared HO-1 and HO-2 protein expression in cerebral microvessels from intact animals and from animals recovering from seizures (4 h after bicuculline administration). As revealed by Western immunoblotting, cerebral microvessels of intact piglets express HO-2 but not HO-1, consistent with our previous observations (27) . HO-2 expression in microvessels was not altered by seizures (Fig. 8). HO-1 was not immunodetectable in cerebral microvessels isolated 4 h after seizure induction (Fig. 8) . These data indicate that seizures do not result in an immediate induction of HO-1 and HO-2 proteins in cerebral microvessels.
Acute effects of seizures on cerebral vascular reactivity during the recovery period. We investigated whether seizures cause acute impairment of cerebral vascular functions in HO-deficient animals. Cerebral vascular responsiveness to endothelium-dependent (hypercapnia and bradykinin) and endothelium-independent (isoproterenol and sodium nitroprusside) stimuli was tested during the seizure recovery period (2 h after bicuculline injection). Although the electric activity in Fig. 6 . CO detection in cortical periarachnoid cerebrospinal fluid (CSF) in newborn pigs. CSF samples (0.5 ml) were collected from the saline control animals (group II, n ϭ 15) or animals treated with SnPP (3 mg/kg iv; group III, n ϭ 10) before and after seizure induction by bicuculline (3 mg/kg iv) at the time intervals indicated. CO concentration was determined by gas chromatography/mass spectrography using 13 CO as an internal standard. Values are means Ϯ SE for each time point. *P Ͻ 0.05 compared with the baseline level; †P Ͻ 0.05 compared with the corresponding time point in the saline control animals. Fig. 7 . Correlation between CO concentration in cortical periarachnoid CSF and time-dependent cerebral vasodilation in response to seizures. CSF samples (0.5 ml) were collected, and pial arteriolar diameter was measured before and after seizure induction by bicuculline (3 mg/kg iv) in saline control animals (group II, n ϭ 15) at the time intervals indicated. CO concentration was detected by gas chromatography/mass spectrography using 13 CO as an internal standard. Fig. 8 . Acute effects of seizures on heme oxygenase (HO)-1 and HO-2 protein expression in cerebral microvessels. Seizures were induced in saline control and SnPP-pretreated animals by bicuculline (3 mg/kg iv). Cerebral microvessels were collected from 1) intact control animals (group I, n ϭ 5); 2) saline control animals during the seizure recovery period (4 h after bicuculline administration; group II, n ϭ 5); and 3) SnPP-treated animals during the seizure recovery period (4 h after bicuculline administration; group III, n ϭ 5). Proteins were resolved by 9% SDS-PAGE (50 g/lane), probed for HO-1/HO-2, and reprobed for actin expression. Top: HO-1, HO-2, and actin detection in cerebral microvessels (a representative immunoblotting). Standards were recombinant rat HO-1 and human HO-2 proteins. Bottom: densitometry analysis of HO-2 expression in cerebral microvessels normalized to the actin amount (HO-2-to-actin ratio, summary data). Values are means Ϯ SE for each treatment group. *P Ͻ 0.05 compared with the intact control values. the brain subsides by 1 h after bicuculline injection (5, 31) , the recovery period is characterized by sustained pial arteriolar dilation (Fig. 4) , increased HR (Fig. 5A) , and moderate metabolic acidosis (Fig. 5D ). As the above data in intact animals demonstrate, HO/CO contributes to cerebral vascular responses to HLL and bradykinin but not to hypercapnia, isoproterenol, or nitroprusside. First, we tested whether seizures alter CO-independent cerebral vascular responses. In saline control animals (HO active), the responsiveness of cerebral arterioles to hypercapnia, isoproterenol, and sodium nitroprusside was completely preserved during the seizure recovery period (Fig. 9) . However, in SnPPtreated animals (HO inhibited at the onset of seizures), cerebral vascular responses to hypercapnia, isoproterenol, and sodium nitroprusside were greatly impaired during the recovery (50-80% inhibition; Fig. 9 ). Second, we tested whether seizures reduce cerebral vascular responsiveness to CO-dependent stimuli, HLL and bradykinin. In saline control animals (active HO), dilator responses to HLL (10 Ϫ8 -10 Ϫ6 M) and bradykinin (10 Ϫ6 -10 Ϫ5 M) were not altered by seizures (Fig.  10) . However, when HO activity was inhibited at the onset of seizures, the recovery period was characterized by great reduction of cerebral vasodilation to HLL and bradykinin (60-80% inhibition; Fig. 10 ). This is not due to the direct inhibitory effects of the HO inhibitor on CO-mediated responses because the effects of SnPP were completely reversed in 2 h of the administration (Figs. 1 and 3) . Overall, in animals with intact HO activity, seizures did not cause acute effects on cerebral vascular reactivity as tested during the recovery period. However, inhibition of HO activity in cerebral microcirculation at the onset of seizures resulted in a great impairment of cerebral vascular responsiveness to endothelium-dependent and -independent stimuli, including CO-dependent and -independent vasodilators.
DISCUSSION
Our novel findings are 1) seizures cause an immediate and sustained increase in CO concentration in cortical periarachnoid CSF, indicating HO activation in the brain; 2) time-dependent cerebral vasodilation in response to seizures correlates with the increase in the CO level in cortical CSF; 3) SnPP, a specific HO inhibitor, greatly reduces CO and cerebral vasodilation responses to seizures; 4) in saline control animals with active HO, seizures do not alter cerebral vascular functions as indicated by preserved reactivity to endothelium-dependent and -independent dilators tested at 2 h of recovery; and 5) HO inhibition at the onset of seizures results in severe impairment of cerebral vascular functions during the recovery period. All together, these findings indicate that activation of HO in the cerebral circulation at the onset of seizures is essential in preventing cerebral vascular dysfunction caused by sustained seizures.
Seizures cause an immediate increase in cerebral blood flow to match metabolic demands of the hyperactive neurons (2, 4, 6, 28, 31, 37) . There are multiple and, possibly, synergistic mechanisms by which seizures induce cerebral hyperemia. Nitric oxide (NO) synthase plays an essential role in seizure-induced cerebral hyperemia in rabbits (13) and in rats (23) , and NO may act as an endogenous anticonvulsant (37) . Products of arachidonic acid metabolism via the phos- Fig. 9 . Acute effects of seizures on cerebral vascular reactivity to CO-independent stimuli. Responses of pial arterioles to hypercapnia (PaCO 2 , 84 Ϯ 5 mmHg), isoproterenol (10 Ϫ5 M), and sodium nitroprusside (10 Ϫ5 M) were detected during the seizure recovery period (2 h after bicuculline administration) in saline control (group II, n ϭ 7) and SnPP (3 mg/kg iv)-pretreated animals (group III, n ϭ 7). Group I (n ϭ 8) was the intact control group (no seizures). Values are means Ϯ SE for each treatment group. *P Ͻ 0.05 compared with intact control values; †P Ͻ 0.05 compared with the saline control animals. Ϫ6 M) and bradykinin (10 Ϫ6 -10 Ϫ5 M) were detected during the seizure recovery period (2 h after bicuculline administration) in saline control animals (group II, n ϭ 7) and SnPP (3 mg/kg iv)-pretreated animals (group III, n ϭ 7). Group I (n ϭ 8) was the intact control group (no seizures). Values are means Ϯ SE for each treatment group. *P Ͻ 0.05 compared with intact control values; †P Ͻ 0.05 compared with the saline control animals.
pholipase A 2 /cyclooxygenase pathways are important in seizure-induced increased blood flow in newborn piglets (6) and in prevention of neurotoxicity (14) . HO, which catalyzes heme conversion to CO, a gaseous vasodilator, and biliverdin/bilirubin, potent antioxidants, contributes to the cerebral hyperemia response to seizures in rats (24) and in newborn piglets (31) .
Bicuculline-induced seizures in newborn pigs are associated with rapid and sustained HO activation in the brain. During basal conditions, the CO level in cortical CSF was 9 Ϯ 2 ϫ 10 Ϫ8 M. At this concentration range, CO has vasodilator effects in pressurized cerebral arterioles (15) and in the cerebral circulation of newborn pigs in vivo (18) . In the brain, constitutive HO-2 is highly expressed in neurons (9, 10, 18) and in non-neuronal cells, including endothelial and smooth muscle cells from cerebral microvessels (18, 27) . HO-1 can be induced by stress factors, including oxidative stress (12, 20) . Therefore, multiple sources in the brain can potentially contribute to CO production in response to seizures. The HO/CO system in the brain is activated at the onset of seizures, and the activation persists for the duration of seizures. The onset of seizures (2-10 min) is characterized by a Ͼ20-fold increase in the CO level and maximal cerebral vasodilation. HO activation (5-to 10-fold) is sustained for the duration of seizures (1 h in our experimental model) (31) . During the recovery period (2 h after seizure induction), CO returns to the basal level. Overall, CO dynamics in cortical CSF follow time-dependent dilation of pial arterioles, suggesting a possibility of causeeffect relationships between CO and cerebral hyperemia during sustained seizures.
Systemically administered SnPP (3 mg/kg) effectively and selectively inhibits HO activity in the brain without changing any systemic parameters (blood pressure and HR, among others). Systemic SnPP reduced the basal CO level in cortical CSF and nearly completely blocked CO-mediated cerebral vasodilation to heme. SnPP did not alter pial arteriolar dilation to sodium nitroprusside and only slightly (Յ30%) decreased responses to hypercapnia and isoproterenol, indicating the specificity of the inhibitor toward HOmediated cerebral vascular responses. When HO activity was inhibited, the CO increase and the cerebral dilation to seizures were greatly reduced. Inhibitory effects of systemic SnPP in the cerebral circulation are time dependent and reversible. Pial arteriolar dilation to heme was blocked in 30 min of SnPP administration, whereas by 2 h the inhibition was completely reversed. Heavy metal protoporphyrins are competitive HO inhibitors (1, (19) (20) (21) and can be displaced from the active site by the substrate. Systemically administered SnPP is accumulated mainly in the liver and kidneys, causing prolonged (up to 7 days) inhibition of HO, whereas only a small amount of SnPP is retained by the brain (1, 19, 20) . It appears that SnPP clearance from the systemic circulation removes its inhibitory effects on HO in the brain. It is possible that systemic SnPP may primarily target endothelial HO in the cerebral microcirculation. Our preliminary data show that SnPP did not produce substantial reduction of neuronal excitation and did not affect the duration of seizures as detected by electroencephalography (unpublished observations).
The excitatory neurotransmitter glutamate is a major excitotoxic factor that contributes to seizures and seizure-related brain injury. Accumulation of extracellular glutamate in the brain during seizures has been reported in patients (34, 38) and in animal models (25, 33) . In a model of bicuculline-induced seizures, blocking inhibitory GABA receptors on glutamatergic neurons enhances glutamate release and activates excitatory amino acid receptors on nerve terminals. Excessive release of glutamate during seizures is a central event in recruiting neurons into epileptic discharges, and glutamate receptors play a crucial role in epilepsy (16, 34) . Glutamate transporter deficiency is also related to epilepsy and brain injury (36) . Another excitatory amino acid, aspartate, also contributes to seizures (25) . We (26) have previously demonstrated that glutamate and aspartate target cerebral microvessels via a glutamate receptor-mediated mechanism. Ionotropic glutamate receptors (NMDA, AMPA, and kainate type) in the cerebral microvasculature are functionally coupled to HO, so that their stimulation rapidly increases CO production (26) and causes endothelium-dependent CO-mediated vasodilation (15) . Therefore, excitatory neurotransmitters may directly target the cerebral microvasculature and stimulate CO production in the cerebral circulation during sustained seizures.
What is the mechanism by which CO production by the brain is rapidly stimulated by seizures? We found neither HO-1 induction nor changes in HO-2 expression in cerebral microvessels 4 h after seizure onset. The rapid increase in CO in the brain (10-20 min) indicates rapid activation of the preexisting constitutive isoform (HO-2). Mechanisms of HO-2 activation at posttranslational level may include protein phosphorylation (10, 17) . In cerebral microvessels, a protein tyrosine kinase-mediated pathway is involved in rapid stimulation of CO production by glutamate (17) . Excitatory neurotransmitters excessively released during seizures may directly target cerebral microvessels, activate vascular HO, and increase production of endogenous CO, which increases cerebral blood flow. Although it is a strong possibility that activation of HO in neuronal populations also contributes to the CO increase in cortical periarachnoid CSF, experimental data connecting neuronal HO activity with seizures are not currently available.
We investigated whether activation of HO/CO system in the brain can protect against seizure-induced cerebral vascular injury. As functional probes for cerebral vascular injury, we tested the reactivity of pial arterioles to physiologically relevant endothelium-dependent and -independent stimuli during the recovery period (2 h after seizure induction). In newborn pigs, cerebral vasodilation to hypercapnia and bradykinin required the presence of intact endothelium (15, 39) . Cerebral dilator responses to isoproterenol, a ␤-adrenoreceptor agonist, and sodium nitroprusside, a NO donor, result from direct stimulation of vascular smooth muscle via a cAMP-or cGMP-dependent mechanisms, respectively. In animals with active HO, cerebral vascular responsiveness to endothelium-dependent and -independent stimuli, including CO-mediated vasodilators (heme and bradykinin), was completely preserved during the seizure recovery period. Other authors (8) also did not find changes in cerebral vascular reactivity to hypercapnia, topical nitroprusside, or adenosine after bicuculline-induced seizures in newborn pigs. Therefore, during the postictal period, cerebral vascular functions are completely preserved in newborn pigs with functionally active HO. In contrast, when HO activity was inhibited at the onset of seizures, cerebral vascular responsiveness to all examined dilators was greatly reduced during the postictal period, thus reflecting vascular injury in the cerebral circulation. Blood-brain barrier integrity is severely affected by seizures (3, 7) , indicating that the endothelium is a likely target for excitotoxic injury. However, in animals with inhibited HO activity, seizure-induced cerebral vascular dysfunction goes beyond endothelial injury and also involves vascular smooth muscle, including both cAMP-and cGMP-dependent signaling pathways. Changes in cerebral vascular reactivity may contribute to brain injury after neonatal seizures.
What is a possible mechanism of HO protection against the seizures-induced vascular injury? Although metabolic acidosis was more accentuated in SnPP-versus saline-treated piglets during the recovery period, the pH values (pH 7.20 Ϯ 0.01 and 7.24 Ϯ 0.01, respectively) remained in physiological range for human infants and newborn piglets. Furthermore, vascular reactivity in the saline-treated piglets during the recovery was not altered compared with that of intact piglets, despite the more significant differences in pH values (pH 7.24 Ϯ 0.01 and 7.31 Ϯ 0.02, respectively). Therefore, it is highly unlikely that the severe cerebral vascular dysfunction observed during the seizure recovery period is due to pH variations.
Because cerebral metabolism increases markedly during seizures and HO inhibition blunts the increase in cerebral blood flow, the result is relative ischemia, which could produce vascular injury. Furthermore, HO activation is not limited to production of vasodilator CO. The products of the HO pathway have protective effects against cell injury and oxidative stress (9, 10, 20, 29, 35) . HO is a major antioxidant system, leading to a decrease in heme, a prooxidant molecule, and an increase in biliverdin and bilirubin, potent antioxidants (9, 20, 29, 35) . In neurons, HO is essential in protection against glutamate-induced apoptosis and oxidative stress (9, 10) . However, molecular mechanisms involved in HO protection against stress-induced cell injury and death are not completely understood.
All together, our data indicate that HO in the brain is absolutely essential in protection from seizure-induced cerebral vascular injury.
